MedTrace Logo

Intravaginal Isosorbide Mononitrate in Addition to Misoprostol Versus Misoprostol Only for Induction of Labor

NCT03523754 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-08-07

No results posted yet for this study

Summary

Evaluation of safety \& efficacy of nitric oxide donors such as intravaginal isosorbide mononitrate in addition to misoprostol Versus misoprostol only for the whole process of induction of labor.

Conditions

  • Induction of Labor

Interventions

DRUG

Isosorbide Mononitrate 40 MG to study group

Isosorbide Mononitrate will be added to Misoprostol, to determine their combined effect on cervical ripening \& induction of labor in study group

Sponsors & Collaborators

  • Dina Yahia Mansour

    lead OTHER

Principal Investigators

  • Hesham M. Harb, MD · Professor of Obstetrics & Gynecology

  • Dina Y. Mansour, MD · Lecturer of Obstetrics & Gynecology

  • Yahia M. A. Mohamed ELBoukhary A.A., M.B.B.Ch · Msc Student, Resident of Obstetrics & Gynecology

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-10-01
Completion
2018-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03523754 on ClinicalTrials.gov